Moderna, Inc. (MRNA) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Moderna, Inc. (MRNA) short-term stock forecast for year 2025, month by month, and long-term MRNA price prediction for years 2025 to 2050. Check MRNA historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest MRNA news and headlines.
1 Month Prediction
$156.89 [271.34%]
3 Month Prediction
$171.06 [304.87%]
6 Month Prediction
$181.11 [328.66%]
1 Year Prediction
$119.18 [182.08%]
3 Year Prediction
$17.01 [-59.73%]
5 Year Prediction
$1.00 [-97.63%]
About Moderna, Inc.
Moderna, Inc., founded in 2010, is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. The company specializes in RNA therapeutics, mainly messenger RNA (mRNA) vaccines, which use mRNA to instruct cells to produce proteins that trigger an immune response. Notably, the company developed one of the first mRNA-based COVID-19 vaccines, SpikeVax, which received emergency use authorization in December 2020.
Moderna, Inc. (MRNA) Historical Performance
IPO Date
Moderna, Inc. (NASDAQ:MRNA) went public on 07 December, 2018.
Change
Since inception, MRNA has increased by 154.52%. In the last 5 years, MRNA has risen from $25.93 to $42.25, a massive 62.94% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $384.86 and a low of $25.93.
52 Week Range
$35.8
$170.47
The current price $42.25 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
MRNA Stock Price History
Based on MRNA stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the MRNA stock has risen from $20.51 - $152.74 to $42.25 - $42.25, which is up 125.8%. Currently, the stock follows upward trend.
Here, we have calculated stock range of MRNA, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $20.51 - $152.74 | $65.21 | 248.51 | 1 Year Change |
| 2021 | $130.95 - $384.86 | $260.37 | 1291.54 | 2 Year Change |
| 2022 | $118.25 - $179.62 | $153.19 | 718.72 | 3 Year Change |
| 2023 | $75.96 - $176.06 | $119.81 | 540.32 | 4 Year Change |
| 2024 | $41.58 - $142.55 | $89.49 | 378.28 | 5 Year Change |
| 2025 | $42.25 - $42.25 | $42.25 | 125.8 | 6 Year Change |
MRNA Price Performance
6-Month Performance
MRNA stock dropped by 45.41% in the last six months.
1-Year Performance
The stock has trended downwards by 54.20% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 72.49%.
5-Year Performance
In the last 5 years, the stock has gone up by 62.94%.
According to Moderna, Inc.'s historical data, below graph gives us the exact picture of how the MRNA stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 2 years and a decline in 3 years.
2020
434.10% ↑
2021
143.11% ↑
2022
29.28% ↓
2023
44.63% ↓
2024
58.19% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Moderna, Inc. (MRNA) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $1.85 B (Q3)
Revenue for Q3 ending 30th September, 2024 increased 739.37% compared to Q2 ending 30th June, 2024.
Annual Revenue: $5.06 B (1Y)
Revenue for trailing 12 months decreased 25.14% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone up from $274.00 million to $5.06 billion, a 1,745.26% change.
Market Capitalization
Moderna, Inc. has a market capitalization of $16.26B, which places MRNA in the large-cap category.
Fundamental Analysis
EPS: $0.03 (Q3), $-12.33 (1Y)
EPS decreased 100.90% since last quarter, and decreased 158.00% since last year.
Net Income: $13.00 M (Q3), $-4.71 B (1Y)
Net Income decreased 101.02% since last quarter, and decreased 156.37% since last year.
Free Cash Flow: $-1.72 B (Q3), $-3.83 B (1Y)
Free Cash Flow increased 17.93% since last quarter, and decreased 183.50% since last year.
Net Profit Margin: 0.70% (Q3), -93.24% (1Y)
Net Profit Margin decreased 100.12% since last quarter, and decreased 175.31% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for MRNA stock. These indicators help you understand Moderna, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for MRNA stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $41.43 |
| SMA50 | $43.53 |
| SMA200 | $87.46 |
| RSI | 61.52 |
| Beta | 1.69 |
SMA20 < Current Price
This signals MRNA stock is in short-term bullish momentum.
SMA50 > Current Price
This signals MRNA stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals MRNA stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for MRNA stock is Neutral. Out of all indicators, 1 indicates bullish signals, 4 signals bearish trends and 4 gives neutral trends. The MRNA stock forecast was last updated on 13 January, 2025.
Moderna, Inc. (MRNA) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $122.09 by the end of 2025, and can reach around $163.69 to $111.19 in 2026. And, the long-term forecast suggests that the stock may further drop to $56.69 - $6.92 in 2028, and $0.75 - $0.98 by 2031. So, the MRNA stock shows a strong upward trend in the next several years.
Short-term MRNA Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-02 | $156.89 | 271.34% |
| 2025-03 | $169.02 | 300.05% |
| 2025-04 | $171.06 | 304.88% |
| 2025-05 | $202.21 | 378.6% |
| 2025-06 | $179.08 | 323.86% |
| 2025-07 | $181.11 | 328.66% |
| 2025-08 | $146.74 | 247.31% |
| 2025-09 | $136.81 | 223.81% |
| 2025-10 | $108.00 | 155.62% |
| 2025-11 | $105.48 | 149.66% |
| 2025-12 | $122.09 | 188.97% |
In 2025, the MRNA stock price is expected to fluctuate between $105.48 and $202.21. According to the monthly forecast, the stock could rise to $122.09 by December 2024. If compared to the MRNA's current price, the stock could gain 188.97% by the end of this year.
Long-term MRNA Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $163.69 | $164.20 | $111.19 | 163.17% |
| 2027 | $85.90 | $71.96 | $48.50 | 14.79% |
| 2028 | $56.69 | $33.55 | $6.92 | -83.62% |
| 2029 | $12.36 | $1.27 | $0.79 | -98.13% |
| 2030 | $1.01 | $1.23 | $1.12 | -97.35% |
| 2031 | $0.75 | $0.86 | $0.98 | -97.68% |
| 2032 | $0.84 | $0.92 | $0.82 | -98.06% |
| 2033 | $0.81 | $0.99 | $1.10 | -97.4% |
| 2034 | $0.99 | $0.96 | $0.98 | -97.68% |
| 2035 | $0.84 | $1.03 | $1.12 | -97.35% |
| 2036 | $1.13 | $1.09 | $0.68 | -98.39% |
| 2037 | $0.81 | $0.83 | $0.81 | -98.08% |
| 2038 | $0.99 | $0.73 | $0.65 | -98.46% |
| 2039 | $1.00 | $0.94 | $1.23 | -97.09% |
| 2040 | $0.90 | $1.27 | $0.89 | -97.89% |
| 2041 | $1.24 | $0.81 | $1.24 | -97.07% |
| 2042 | $0.91 | $0.85 | $0.96 | -97.73% |
| 2043 | $0.88 | $1.17 | $0.87 | -97.94% |
| 2044 | $1.13 | $1.13 | $1.23 | -97.09% |
| 2045 | $1.11 | $1.14 | $1.29 | -96.95% |
| 2046 | $1.00 | $1.11 | $0.97 | -97.7% |
| 2047 | $0.69 | $1.22 | $0.92 | -97.82% |
| 2048 | $0.98 | $1.04 | $0.94 | -97.78% |
| 2049 | $0.88 | $1.04 | $0.84 | -98.01% |
| 2050 | $1.01 | $1.05 | $1.13 | -97.33% |
| 2051 | $0.96 | $1.24 | $0.88 | -97.92% |
Moderna, Inc. (MRNA) Stock Price Prediction & Forecast 2025
At the start of 2025, the MRNA stock was at $42.25. Today, it is trading at $42.25, which is 0.00% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $122.09 by December 2025 with a 188.97% change.
Moderna, Inc. (MRNA) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the MRNA stock. During this period, the MRNA's price is forecasted to shift from $163.69 to $1.12, which is -99.32% loss.
In 2026, the stock would possibly open at $163.69, escalates to $164.20 by mid-year, and wraps up at $111.19, reflecting a 163.17% increase from today's price. Further moving to 2030, the stock can kick off the year at $1.01, soar to $1.23 by mid-year, and finish at $1.12, which is -97.35% change from current price.
Moderna, Inc. (MRNA) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.75 to $0.89, which is up -97.68%
In 2031, we can expect MRNA to fluctuate between $0.75 and $0.98, a shift indicating a -97.68% loss by year-end compared to current price. And Until 2040, MRNA can likely vary from $0.89 to $0.90. By the end of 2040, the stock could record a -97.89% fall from today's stock price.
Moderna, Inc. (MRNA) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the MRNA stock can see an a downturn from $1.24 to $1.13 in this period. In 2041, the stock can experience a low of $0.81 by mid-year, closing the year at $1.24. This results in a -98.08% decrease from today.
Moving towards the end of 2050, MRNA is projected to open the year at $1.01. The stock may peak to $1.05 during mid-year and finish the year at $1.13. Compared to the stock's current price, this translates to an overall loss of -97.34% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
MRNA Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| IPA | ImmunoPrecise Antibodies Ltd. | - | $0.53 | 28.28% ▲ | $117.56 ▲ |
| NVAX | Novavax, Inc. | - | $9.31 | 15.86% ▲ | $74.57 ▲ |
| HOTH | Hoth Therapeutics, Inc. | - | $2.47 | 0.00% ▼ | -23.28 ▼ |
| SANA | Sana Biotechnology, Inc. | - | $4.49 | -0.11% ▼ | $225.59 ▲ |
| NRXP | NRx Pharmaceuticals, Inc. | - | $4.52 | 0.00% ▼ | -12.84 ▼ |
Last updated Jan 13 at 2:08 PM
MRNA : Buy, Sell Or Hold?
Analyst Ratings
Based on 23 analysts, 3 rated as a strong buy, 5 recommended a buy, 13 suggested a hold, 0 advised a sell, and 2 indicated a strong sell.Three months ago, out of 23 analysts, 2 analysts gave a strong buy rating, 4 a buy rating, 15 a hold rating, 0 advised selling, and 2 suggested a strong sell.So, according to analyst ratings, the recommendation for MRNA stock is Hold.
Expert Analysis
According to MRNA short-term and long-term forecast, Moderna, Inc. shares are projected to go down by 97.33%, and reach a value of $1.13 per share by 2050.
As per technical analysis, indicators show a Neutral sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, MRNA has recorded 9/30 green days, which reflects a 45.0% positivity rate with a price volatility of 0.04%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that MRNA stock is undervalued. So, Based on MRNA prediction and analysis, it may be the best time to hold MRNA stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "MRNA” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.
